Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP212358Z

HM74A/PUMA-G/GPR109A/NIACR1 Antibody (MM0329-6S24), Alexa Fluor™ 700, Novus Biologicals™
SDP

Catalog No. NBP212358Z Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP212358Z 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP212358Z Supplier Novus Biologicals Supplier No. NBP212358AF700
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

HM74A/PUMA-G/GPR109A/NIACR1 Monoclonal specifically detects HM74A/PUMA-G/GPR109A/NIACR1 in Human samples. It is validated for Flow Cytometry.

Specifications

Antigen HM74A/PUMA-G/GPR109A/NIACR1
Applications Western Blot, Flow Cytometry, Immunohistochemistry
Classification Monoclonal
Clone MM0329-6S24
Conjugate Alexa Fluor 700
Dilution Western Blot, Flow Cytometry, Immunohistochemistry
Gene Accession No. Q8TDS4.1
Gene Alias GPR109A, HCA2, hydroxycarboxylic acid receptor 2, NIACR1
Gene Symbols HCAR2
Host Species Rat
Immunogen Human recombinant HM74A/PUMA-G/GPR109A/NIACR1
Purification Method Protein G purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 338442
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG2
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.